Psychometric Evaluation of the Quality of Life Interview, Brief Version, in Injection Drug Users

    loading  Checking for direct PDF access through Ovid


The authors investigated the psychometric characteristics of the Quality of Life Interview, Brief Version (QOLI–BV; A. F. Lehman, 1995) in 126 injection drug users recruited for a clinical trial. The QOLI–BV assesses global and domain-specific quality of life. Participants completed the instrument at baseline and 3 and 6 months later. Most scales showed acceptable internal consistency. Convergent and discriminant validity were demonstrated through correlations with the SF-36, the Beck Depression Inventory, and demographic variables. Scale means rose over time, suggesting that the QOLI–BV is sensitive to change. Unexpectedly, lower baseline QOLI–BV scores predicted opiate abstinence at follow-up. The QOLI–BV appears to be an acceptable quality-of-life measure for use in clinical trials of opioid dependence treatments.

    loading  Loading Related Articles